SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DYAX: Dyax Corp.
DYAX 38.410.0%Jan 25 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: aknahow2/14/2002 11:45:35 AM
   of 197
 
Like the company, was surprised about the fx losses. Would have thought they could have hedged their exposure. Conference call mentioned several times the negative impact on their earnings on cash balances. Increased my position, even though it is obvious the market did not think highly of what was said.

Comments on the impact of low interest rates make me think about the impact on those who raised a billion or so at 9% using qualified special purpose entities and are now earning at most 2% on the funds. Translates to a $70 million loss, per year, if you ask me.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News